Corgard and Aimovig drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Corgard (nadolol) and Aimovig (erenumab-aooe). Common drug interactions include dyspnoea among females and headache among males.

The phase IV clinical study analyzes what interactions people have when they take Corgard and Aimovig. It is created by eHealthMe based on reports of 79 people who take the same drugs from the FDA, and is updated regularly.

What is Corgard?

Corgard has active ingredients of nadolol. It is often used in high blood pressure. eHealthMe is studying from 3,342 Corgard users. Check the latest studies of Corgard.

What is Aimovig?

Aimovig has active ingredients of erenumab-aooe. eHealthMe is studying from 49,930 Aimovig users. Check the latest studies of Aimovig.

eHealthMe: drug outcomes in the real world

eHealthMe runs one of the largest post-marketing drug safety studies in the world. We study millions of patients and 5,000 more each day. Our data-driven phase IV clinical trials have been referenced on 800+ peer-reviewed medical publications including The Lancet, Mayo Clinic Proceedings, and Nature. Tools to study our phase IV findings are available to the public, anonymous and free >>>.

On Sep, 01, 2026

79 people who take Corgard and Aimovig together, and have interactions are studied.

What are the common drug interactions of Corgard and Aimovig, by gender? *:

female:

Dyspnoea (difficult or laboured respiration)
Extrapyramidal disorder (involuntary muscle spasms in the face and neck)
Neovascularisation (development of tiny, abnormal, leaky blood vessels inside the eye)
Paradoxical drug reaction
Diarrhoea
Balance disorder
Facial pain
Fatigue (feeling of tiredness)
Myalgia (muscle pain)
Paraesthesia (sensation of tingling, tickling, prickling, pricking, or burning of a person's skin with no apparent long-term physical effect)

male:

Headache (pain in head)
Nausea (feeling of having an urge to vomit)
Vomiting

What are the common drug interactions of Corgard and Aimovig, by age (0-1 to 60+)? *:

0-1:

n/a

2-9:

n/a

10-19:

n/a

20-29:

n/a

30-39:

Headache (pain in head)
Nausea (feeling of having an urge to vomit)
Vomiting
Abdominal pain lower
Decreased appetite
Irritability
Weight decreased

40-49:

Balance disorder
Drug ineffective
Facial pain
Nausea (feeling of having an urge to vomit)
Paraesthesia (sensation of tingling, tickling, prickling, pricking, or burning of a person's skin with no apparent long-term physical effect)
Vision blurred
Back pain
Fatigue (feeling of tiredness)
Myalgia (muscle pain)
Temperature intolerance (inability to go in temperature)

50-59:

Abdominal pain
Anuria (failure of the kidneys to produce urine)
Cough
Drug ineffective
Dyspepsia (indigestion)
Dyspnoea (difficult or laboured respiration)
Extrapyramidal disorder (involuntary muscle spasms in the face and neck)
Nausea (feeling of having an urge to vomit)
Neovascularisation (development of tiny, abnormal, leaky blood vessels inside the eye)
Paradoxical drug reaction

60+:

Abdominal pain
Anuria (failure of the kidneys to produce urine)
Paradoxical drug reaction
Weight decreased
Cough
Diarrhoea
Drug ineffective
Dyspepsia (indigestion)
Dyspnoea (difficult or laboured respiration)
Extrapyramidal disorder (involuntary muscle spasms in the face and neck)

What are the existing conditions these people have? *

Migraine (headache): 77 people, 97.47%
Nausea (feeling of having an urge to vomit): 4 people, 5.06%

* Approximation only. Some reports may have incomplete information.

Do you take Corgard and Aimovig?

- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously